Europe’s medicines regulator has declared the vaccine developed by the University of Oxford and AstraZeneca safe for use, paving the way for countries to lift temporary restrictions on the drug.

The European Medicines Agency’s safety committee said at a press conference on 18 March that the drug presented no causal link to blood clotting events, following a series of emergency meetings on the treatment.